IOL Chemicals & Pharmaceuticals Share Price ₹134

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of IOL Chemicals & Pharmaceuticals Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	587	563	545	520	504	502	526	523	528	552	568	580	619
Expenses +	491	490	481	476	454	452	484	476	465	490	510	523	527
Operating Profit	96	73	64	44	50	51	42	47	63	62	57	57	93
OPM %	16%	13%	12%	9%	10%	10%	8%	9%	12%	11%	10%	10%	15%
Other Income +	9	7	7	8	8	7	6	4	5	7	7	-6	2
Interest	5	4	4	4	3	2	4	4	4	4	3	4	3
Depreciation	12	14	16	16	16	17	18	19	19	20	20	20	20
Profit before tax	88	62	51	32	38	39	26	28	45	46	41	28	71
Tax %	25%	25%	26%	28%	25%	24%	26%	26%	30%	25%	26%	25%	25%
Net Profit +	65	46	38	23	28	30	19	21	32	34	30	21	53
EPS in Rs	2.22	1.57	1.29	0.79	0.96	1.01	0.65	0.70	1.08	1.16	1.02	0.70	1.81

Financials of IOL Chemicals & Pharmaceuticals Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	385	580	711	983	1,685	1,894	1,967	2,184	2,217	2,133	2,079	2,319
Expenses +	373	529	608	863	1,276	1,321	1,375	1,927	1,990	1,901	1,877	2,050
Operating Profit	11	51	102	120	410	574	592	257	227	232	202	269
OPM %	3%	9%	14%	12%	24%	30%	30%	12%	10%	11%	10%	12%
Other Income +	1	1	1	6	10	16	24	17	25	30	22	10
Interest	59	61	68	64	51	21	6	8	16	16	15	15
Depreciation	29	30	30	30	32	36	39	43	46	63	72	80
Profit before tax	-75	-39	6	31	336	533	571	223	189	183	138	184
Tax %	-12%	4%	21%	12%	30%	32%	22%	26%	26%	26%	27%	25%
Net Profit +	-67	-40	5	28	237	361	445	166	140	135	101	138
EPS in Rs	-2.80	-1.42	0.17	0.99	8.32	12.70	15.15	5.64	4.77	4.61	3.44	4.69
Dividend Payout %	0%	0%	0%	0%	0%	5%	8%	14%	17%	22%	23%	21%

Financials of IOL Chemicals & Pharmaceuticals Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	48	56	56	56	57	57	59	59	59	59	59	59
Reserves	160	129	132	160	417	757	1,202	1,332	1,448	1,553	1,629	1,740
Borrowings +	400	453	447	422	284	59	3	44	80	33	117	135
Other Liabilities +	94	135	182	214	184	297	347	526	434	600	577	653
Total Liabilities	702	772	817	852	942	1,170	1,610	1,960	2,021	2,244	2,382	2,587
Fixed Assets +	403	400	374	406	412	469	512	561	751	933	1,170	1,183
CWIP	4	4	21	7	27	19	48	105	90	101	22	94
Investments	0	0	0	0	0	0	1	2	20	21	21	21
Other Assets +	295	369	422	439	503	682	1,048	1,292	1,159	1,190	1,168	1,289
Total Assets	702	772	817	852	942	1,170	1,610	1,960	2,021	2,244	2,382	2,587

Financials of IOL Chemicals & Pharmaceuticals Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	-47	18	83	120	273	471	380	91	123	290	179	214
Cash from Investing Activity +	-5	-27	-23	-50	-63	-184	-317	-121	-119	-191	-154	-198
Cash from Financing Activity +	50	9	-60	-70	-197	-272	-58	-2	-4	-92	46	-29
Net Cash Flow	-2	-0	1	-1	13	15	4	-31	-0	7	70	-13
Free Cash Flow	-53	-9	61	71	213	391	272	-60	-86	18	-34	44
CFO/OP	-413%	34%	82%	105%	83%	102%	88%	60%	75%	144%	97%	94%

Financials of IOL Chemicals & Pharmaceuticals Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	31	55	58	54	43	52	56	79	83	81	90	95
Inventory Days	279	201	201	109	66	64	98	95	77	111	95	91
Days Payable	92	102	115	83	42	62	79	95	74	123	112	118
Cash Conversion Cycle	218	154	144	80	67	55	74	79	86	69	73	68
Working Capital Days	59	39	36	23	43	46	66	71	72	71	58	53
ROCE %	-3%	4%	12%	15%	56%	68%	54%	18%	14%	12%	9%	11%